Cellosaurus logo
expasy logo

Cellosaurus 1383D2 (CVCL_UP38)

[Text][XML][JSON]
Cell line name 1383D2
Synonyms HPS1005
Accession CVCL_UP38
Resource Identification Initiative To cite this cell line use: 1383D2 (RRID:CVCL_UP38)
Comments From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
Population: Asian.
Omics: Genomics; Whole genome sequencing.
Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
HLA typing Source: PubMed=30853558
Class I
HLA-AA*02:07,32:01
HLA-BB*15:02,51:01
HLA-CC*08:01;14:02
Class II
HLA-DQDQA1*03:03,06:01
DQB1*03:01,03:02
HLA-DRDRB1*04:05,12:01
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy Children:
CVCL_C1FK (1383D2-B2M-KO #1)CVCL_C1FL (1383D2-B2M-KO #2)
Originate from same individual CVCL_UP39 ! 1383D6
Sex of cell Male
Age at sampling 36Y
Category Induced pluripotent stem cell
Publications

PubMed=28453617; DOI=10.1093/biolre/iox038
Shihori Yokobayashi, Keisuke Okita, Masato Nakagawa, Tomonori Nakamura, Yukihiro Yabuta, Takuya Yamamoto, Mitinori Saitou;
Clonal variation of human induced pluripotent stem cells for induction into the germ cell fate.
Biol. Reprod. 96:1154-1166(2017)

PubMed=30853558; DOI=10.1016/j.stem.2019.02.005
Huai-Geng Xu, Bo Wang, Miyuki Ono, Akihiro Kagita, Kaho Fujii, Noriko Sasakawa, Tatsuki Ueda, Peter Gee, Misato Nishikawa, Masaki Nomura, Fumiyo Kitaoka ...Show all 16 authors... , Tomoko Takahashi, Keisuke Okita, Yoshinori Yoshida, Shin Kaneko, Akitsu Hotta; Show fewer authors
Targeted disruption of HLA genes via CRISPR-Cas9 generates iPSCs with enhanced immune compatibility.
Cell Stem Cell 24:566-578.e7(2019)

Patent=US20200407693
Akitsu Hotta, Huai-Geng Xu, Shin Kaneko, Bo Wang;
Method for producing low-antigenic cell.
Patent number US20200407693, 31-Dec-2020

Cross-references
Cell line collections (Providers) RCB; HPS1005
Encyclopedic resources Wikidata; Q93298761
Entry history
Entry creation25-Feb-2019
Last entry update10-Apr-2025
Version number8